Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-12 11:14:33 ET
Ipsen S.A. (IPSEY) Q4 2025 Earnings Call February 12, 2026 8:00 AM EST
Company Participants
David Loew - MD, CEO & Director
Aymeric Le Chatelier - Executive VP & CFO
Conference Call Participants
Charles Pitman - Barclays Bank PLC, Research Division
Xian Deng - UBS Investment Bank, Research Division
Simon Baker - Rothschild & Co Redburn, Research Division
Richard Vosser - JPMorgan Chase & Co, Research Division
Victor Floch - BNP Paribas, Research Division
Lucy-Emma Codrington-Bartlett - Jefferies LLC, Research Division
...
Read the full article on Seeking Alpha
For further details see:
Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript
Ipsen
NASDAQ: IPSEF
IPSEF Trading
100.0% G/L:
$113.13 Last:
5 Volume:
$0 Open:
IPSEF Latest News
February 27, 2026 06:20:11 am
Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma
February 12, 2026 01:00:00 am
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
January 27, 2026 01:00:00 am
Pierrick Lefranc appointed as Executive Vice President Technical Operations, member of Executive Leadership Team
